评论文章
A Multicenter, Randomized, Double Blind, Placebo Controlled Phase II Trial of Intravenous Inflammasome Inhibitor (NuSepin) for the Treatment of COVID-19 Patients
研究文章
1 美托洛尔缓释片整片及半片体内外评价
查看更多